Company Analysis

BioVie Inc. (BIVI)

Nasdaq: BIVI · Pharmaceutical Preparations · Carson City, NV · filing with the SEC since 2013
Grade4.6
◀ Past 3.3● Present 4.2▶ Future 5.8
6 est.

Who runs BioVie Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Do Cuong V
President & CEO. First filing Jan 2018, latest Aug 28, 2026, 4 filings in all.
Officers reporting now
3
of 8 people with a filing in the last fifteen months
Directors reporting now
5
21 people on the record since 2016
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Do Cuong VPresident & CEOJan 2018Aug 28, 2026none
Kim Joanne WendyChief Financial OfficerMar 2019Aug 28, 2026none
Palumbo Joseph MChief Medical OfficerNov 2021Aug 28, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Chappell Amy SuzondirectorOct 2025Aug 28, 2026none
Farag Kameel D.directorOct 2025Jan 9, 2026none
Lang James PauldirectorJul 2017Jan 9, 2026none
Rogich SigmunddirectorNov 2020Jan 9, 2026none
Sherman Michael EdwarddirectorJan 2018Jan 9, 2026none
Earlier names on the record13, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton BIVI · research, not advice